Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind lixivaptan trial in euvolemic hyponatremia (SIADH and related conditions)
2008-003191-21Phase 3Completed
- Sponsor
- CardioKine
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Euvolemic hyponatremia, syndrome of inappropriate antidiuresis (SIAD) and hyponatraemia comparing Lixivaptan with Placebo (2 arms). Primary endpoint: Change from baseline in serum sodium on Day 7. Started Jun 2009; status: completed.
02
Drugs
lixivaptan
03
Conditions
Euvolemic hyponatremiasyndrome of inappropriate antidiuresis (SIAD)hyponatraemia
Beyond the preview
Go deeper on 2008-003191-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003191-21.